Safety issues highlighted with newer oral anticoagulant drug
Analysis of ‘real-life’ data comparing newer direct oral anticoagulants with warfarin has identified adverse drug reactions (ADRs) ‘not previously associated’ with the new treatments, including hip fracture.

Direct oral anticoagulants, such as dabigatran, rivaroxaban and apixaban, are becoming increasingly popular alternatives to warfarin in patients with atrial fibrillation owing to their ability to produce similar effects without the need for regular coagulation monitoring....

http://www.pharmaceutical-journal.com/news-and-analysis/news/safety-issues-highlighted-with-newer-oral-anticoagulant-drugs/20202191.article
Like
Comment
Share